UK markets closed

Galmed Pharmaceuticals Ltd. (GLMD)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.3775-0.0096 (-2.48%)
As of 12:48PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
3,569
3,569
12,995
27,220
26,082
Selling general and administrative
3,923
3,923
4,656
5,661
4,128
Total operating expenses
7,492
7,492
17,651
32,881
30,210
Operating income or loss
-7,492
-7,492
-17,651
-32,881
-30,210
Total other income/expenses net
216
216
-490
-105
278
Income before tax
-6,912
-6,912
-17,866
-32,467
-28,771
Income tax expense
-
-
-
-
0
Income from continuing operations
-6,912
-6,912
-17,866
-32,467
-28,771
Net income
-6,912
-6,912
-17,866
-32,467
-28,771
Net income available to common shareholders
-6,912
-6,912
-17,866
-32,467
-28,771
Basic EPS
-3.02
-
-10.65
-19.80
-20.25
Diluted EPS
-3.02
-
-10.65
-19.80
-20.25
Basic average shares
2,832
-
1,676
1,640
1,419
Diluted average shares
2,832
-
1,676
1,640
1,419